Li Kang Biomedical Co., Ltd. (6242.TWO) Key Statistics
$33.00TWO: 6242.TWOMarket Cap $1.07B
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Li Kang Biomedical Co., Ltd. (6242.TWO), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
14.12
P/B ratioShare price divided by book value per share.
1.27
P/S ratioMarket value divided by annual revenue.
1.86
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
10.94
EV / RevenueEnterprise value against annual revenue.
1.80
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
7.08%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
67.23%
Operating marginRevenue left after operating costs.
16.70%
Net marginRevenue left after every cost, including tax and interest.
13.32%
Return on equityProfit as a percentage of shareholders’ equity.
9.12%
Return on assetsProfit as a percentage of total assets.
4.84%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
1.04
Quick ratioThe same, excluding inventory.
0.77
Debt to equityTotal borrowings against shareholders’ equity.
0.15
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$2.38
Book value per shareShareholders’ equity divided by shares outstanding.
$26.50
Shares outstandingShares currently issued.
31,807,000
Market capitalisationShare price times shares outstanding.
$1.07B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
130
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
5.87%
Payout ratioShare of profit paid out as dividends.
82.88%
Li Kang Biomedical Co., Ltd. (6242.TWO) statistics — frequently asked questions
What is Li Kang Biomedical Co., Ltd.'s P/E ratio?
Li Kang Biomedical Co., Ltd. (6242.TWO) trades on a price-to-earnings ratio of 14.12.
What is Li Kang Biomedical Co., Ltd.'s return on equity?
Li Kang Biomedical Co., Ltd. (6242.TWO) reports a return on equity of 9.12%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Li Kang Biomedical Co., Ltd. carry?
Li Kang Biomedical Co., Ltd. (6242.TWO) has a debt-to-equity ratio of 0.15, which compares total borrowings with shareholders' equity.
What is Li Kang Biomedical Co., Ltd.'s profit margin?
Li Kang Biomedical Co., Ltd. (6242.TWO) keeps 13.32% of revenue as net profit after every cost, including tax and interest.